
Why cancer care needs to include oral health
Persistent burden and patchy surveillance
Globally, an estimated 3.5 billion people are affected by oral diseases. While many countries have seen improved oral health indicators in recent decades, India has not kept pace. Oral disorders remain one of the leading causes of disability in the country, affecting individuals across age groups and socioeconomic strata.
India's last national oral health survey was conducted in 2007–08. Since then, there has been no updated, nationwide data, leading to significant blind spots in planning and policy. The Draft National Oral Health Policy (2021) outlines the need for baseline data by 2025 and proposes a 15% reduction in mortality and morbidity due to orofacial diseases by 2030. However, without reliable surveillance systems or integration with broader public health efforts, these goals remain aspirational.
Also, the World Health Organization has recognised oral health as a vital component of non-communicable disease (NCD) prevention, calling for stronger integration between dental and general medical care.
Cancer risk and the oral cavity
A recent study titled 'Oral Health and its Expanding Role in Systemic Disease, Cancer Outcomes, and Public Health', published in The Lancet, by Abhishek Shankar, assistant professor and Vaibhav Saini, scientist from the Department of Radiation Oncology at AIIMS, Delhi, underlines how oral hygiene may serve as a modifiable risk factor in cancer. Drawing on data from the International Head and Neck Cancer Epidemiology (INHANCE) consortium, the authors report that good oral hygiene is associated with a modest reduction in head and neck cancer risk.
Observational data further suggest a possible association between periodontal disease, root canal infections, and increased risk of pancreatic and upper gastrointestinal cancers. 'The evidence certainly points towards considering oral health as an integral part of cancer care,' the study investigators note, emphasising the need to embed dental care within oncology pathways.
Oral pathogens are also implicated in cancer biology. Porphyromonas gingivalis and Prevotella intermedia, commonly found in chronic gum disease, are increasingly understood to influence tumour development. 'P. gingivalis evades immune surveillance, invades host tissues, and promotes cancer proliferation,' write Dr. Shankar and Dr. Saini. 'P. intermedia, on the other hand, alters the tumour microenvironment and down regulates tumour suppressors.'
Syed Ismail Nawab John, clinical lead at MGM Cancer Institute, Chennai, adds that bacteria such as Fusobacterium nucleatum have been linked with colorectal cancer by altering local immune responses. 'Bacterial byproducts such as butyrate can damage DNA and disrupt cellular repair. In a large cohort study published in Gut in 2018, individuals with severe periodontal disease had a 20–50% higher risk of developing pancreatic and colorectal cancers.'
Vijay Pillai, senior consultant and chief of head and neck surgical oncology at Narayana Health City, Bengaluru, notes that oral dysbiosis -- an imbalance or disruption in the community of microorganisms (microbiome) that naturally inhabit the oral cavity, especially involving Fusobacterium and Bacteroides may contribute to a pro-inflammatory state that favours tumour progression. 'Early detection of potentially malignant lesions can significantly downstage disease and improve outcomes,' he says.
Impact on cancer treatment
Oral health also has implications for cancer therapy. Radiotherapy for head and neck cancers disrupts the oral microbiome, often suppressing protective bacteria and allowing harmful strains to thrive. 'Patients with periodontal disease who undergo radiotherapy are particularly susceptible to complications such as impaired bone healing,' say the AIIMS researchers. Retention of natural teeth and frequent dental consultations are linked to better survival in head and neck cancer patients.
In contrast to Western countries, where oral health data are routinely collected through registries, India and much of Southeast Asia lack comprehensive oral health surveillance. 'Region-specific data is essential for relevant decision-making,' stress Dr. Shankar and Dr. Saini. 'Existing registries and collaborations are underutilised unless integrated into national cancer care frameworks.'
Dr. John concurs, calling the absence of surveillance a major public health downside. 'Integrating dental metrics into cancer registries would be a strategic step forward.'
Towards integrated prevention
Evidence suggests that community-level interventions such as school toothbrushing programmes, fluoride education and low-cost point-of-care diagnostics like aMMP-8 testing can reduce systemic inflammation and potentially lower cancer risk. A study in the Journal of Clinical Periodontology showed that professional periodontal treatment led to decreased levels of CRP and IL-6, both biomarkers associated with cancer progression.
'Oral health should no longer be siloed,' says Dr. John. Experts are urging the inclusion of oral health in national cancer control plans, school health programmes, and tobacco cessation curricula. Policy changes such as mandatory front-of-pack nutrition labels and bans on cartoon characters in junk food advertising are also being advocated to reduce early-life exposure to oral and systemic health risks.
Community-based dental interventions, particularly for low-income communities, may help reduce the prevalence of periodontal disease and the systemic burden of oral pathogens. By reducing inflammatory markers and enhancing early detection, these efforts could play a role not only in improving oral hygiene but in reducing the broader burden of cancer and other non-communicable diseases.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
5 hours ago
- Time of India
10 fire engines take 3 hours to douse blaze that hits 67-year-old unit of Bengal's legacy med co
1 2 Kolkata: A fire broke out at a Dey's Medical factory on Bondel Road around 4 pm on Saturday, sending thick black smoke billowing across the neighbourhood and forcing residents of nearby buildings to evacuate. While nobody was injured in the fire, three firemen fell ill after inhaling toxic fumes while working inside the affected building. The factory was closed at the time but the blaze at its pharmaceutical unit sparked widespread panic, with residents rushing out of their homes and traffic coming to a standstill in the area. Ten fire engines took nearly three hours to control the blaze. The billowing smoke was so dense that it was visible from as far as Park Circus, a few motorists said. The exact cause of the fire was yet to be ascertained. You Can Also Check: Kolkata AQI | Weather in Kolkata | Bank Holidays in Kolkata | Public Holidays in Kolkata "The fire broke out in the pharmaceutical unit of the factory. Barring the guards, there was nobody inside the factory as Saturday is a holiday. As no work was on, a short circuit could have caused the fire, but the reason can be confirmed only after a forensic inspection," said a fire department officer, supervising the rescue operation. "The pocket where the fire started had some packaging chemicals. It spread fast," said one of the firefighters on the scene. Sources said the Dey family, which owned the business, had recently invested Rs 40 crore to upgrade the manufacturing facility to conform to the World Health Organization's Good Manufacturing Practices (GMP). "The manufacturing facility was upgraded in the past one-and-a-half years. We are praying and hoping the fire did not cause much damage to the facility as 70% of our drugs are manufactured at this unit," said company director Rishav Dey. The factory will resume operations only after the investigation is completed. "At first, we thought it was just someone burning waste, but the smoke quickly turned dense and dark," said Namita Chowdhury, a resident of 43, Bondel Road, located right opposite the factory. "There was a lot of shouting and confusion. People were coming out on balconies and calling their neighbours." Chowdhury said six members of the family, including two children, were inside the house when the incident took place. No one was injured, though all suffered a bout of coughing amid the smoke. The blaze caused major traffic disruptions on Syed Amir Ali Avenue, Rifle Range Road, Palm Avenue and the Bondel Gate flyover, as fire engines and emergency personnel cordoned off the area. Picnic Garden resident Fahim Ansari, who was stuck in the jam on Rifle Range Road, described the moment he realised something was seriously wrong. "As I rode towards the Bondel Gate flyover, the entire area looked like it was under a dark cloud. The Dey's Medical factory on Bondel Road was inaugurated in 1958 by then former chief minister Bidhan Chandra Roy. Though Dey's Medical has multiple manufacturing facilities now, the Bondel Gate factory is the only one, where pharmaceutical products, including tablets, syrups and eye drops, are manufactured. The other unit makes cosmetic products, including body and hair oil. There are also some factories outside the state to which it contracts medicine manufacturing. Dey's Medical founder Bhupendranath Dey forayed into the pharmaceutical business in 1941, when he rented a space on Lindsay Street opposite New Market to establish Dey's Medical Stores. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !


NDTV
2 days ago
- NDTV
Lung Cancer No More Smokers' Disease: Experts Reveal How Everyone Is Affected, Even Children
August 1 is annually observed as World Lung Cancer Day to raise awareness about the type of cancer that originates in the lungs and spreads to other parts of the body. Smoking is one of the primary causes of lung cancer, but alarming trends suggest that lung cancer can "no longer be seen as a smoker's disease" as it is affecting men, women and even children who don't smoke. "While smoking remains the leading cause, globally and in India, a concerning number of patients diagnosed today have never smoked a cigarette, and it's on the rise," Dr Srivatsa Lokeshwaran, Lead Consultant and Head of Department - Interventional Pulmonology and Lung Transplant, Aster Whitefield Hospital, Bengaluru, told NDTV. This growing trend is supported by Indian studies and global data that suggests a change being driven by environmental, occupational and/or genetic risk factors. A Lancet study, published in 2022, found that long-term exposure to fine particulate matter (PM2.5) caused an increase in the incidence rate of non-small cell lung cancer in non-smokers in urban and industrialised regions. In most Indian cities like Delhi, Bengaluru, and Kanpur, pollution levels have become too high to be considered acceptable by the World Health Organization (WHO). Air pollution would not merely irritate lung tissues; it can also damage DNA, thus, potentially creating cancer by the chronic exposure to pollutants such as soot, nitrogen dioxide, and benzene. Are Children At Risk? Can They Get Lung Cancer Or Other Severe Lung Diseases? Dr Shishir Bhatnagar, Senior Consultant - Paediatrician and Neonatologist at Cloudnine Group of Hospitals, Noida, told NDTV that lung cancer as such in children is "not very common". The cancers in the lungs are basically carcinoids, adenocarcinomas and subtle pleuropulmonary blastomas. Most of these cancers may have their origin rarely from smoking and genetic factors. "More commonly in children, the lungs are affected by inflammation and infections. The inflammations are basically contributory and they are responsible for creating conditions like asthma and bronchitis," Dr Bhatnagar said. "Infections like bronchopneumonias, bronchitis, bacterial bronchitis and bronchiolitis are also contributed to by the environmental factors, including smoking and environmental smoke and dust." The smoking at the microbiological level can affect the immune system and weaken it by affecting the annular macrophage system. It also disturbs the microbiome of the airways, thereby increasing the biological injuries in them. At the cellular level, it affects the DNA and makes it more prone to inflammation and cancer. According to Dr Bhatnagar, the bigger issue is the serious lung harm from environmental exposures during early childhood. Children who live in high pollution neighbourhoods, and/or have been exposed to passive smoke, unclean fuels, or multiple respiratory infections as infants, potentially have sustained damage to their lungs, some of which may lead to chronic disease (bronchiectasis, asthma, lung cancer) in the future. A study published in 2023 in The New England Journal of Medicine demonstrated that children exposed to high levels of PM2.5, impaired lung function, asymmetrically slowed lung development, and had the potential for life-long impairment related to lung function. Serious Concerns Over Vaping Experts are also concerned about the rising trend of vaping. Dr Bhatnagar said that vaping is some sort of mechanism where the toxins produced are less and are not equivalent to smoking. "The toxins are less, but they have high nicotine dependence. There are very high chances that in adolescence this can become a trouble, and it is actually a problem these days," he said, further adding that vaping can contribute and can actually go on to smoking. "Children may not have early symptoms of cancer, but a persistent cough, wheezing without being diagnosed with asthma, recurrence of pneumonia, or even chest pain of unknown origin, must be taken seriously," Dr Bhatnagar said. Children must be protected from indoor air pollution, and also reduce exposure to passive smoke, while treating infections early, as lung health is often forgotten. Major Causes Of Lung Cancer The most frequent cause is smoking, responsible for more than 70 per cent of cases and 90 per cent of diagnoses. "Tobacco smoke harbours more than 60 carcinogens, and the risk is directly proportional to the intensity of smoking. The world's second-largest consumer of tobacco is India, which has 267 million consumers of tobacco, and tobacco is responsible for 27% of all cancers," Dr Vinayak Maka, Consultant - Dept of Medical Oncology, Ramaiah Institute of Oncosciences, Ramaiah Memorial Hospital, told NDTV. For all causes except tobacco, environmental and occupational risk factors are important: Passive Smoking: Significantly boosts risk. Radon Gas: The Second greatest risk factor after smoking, particularly in smokers. Occupational Exposure: Chemicals like asbestos, arsenic, and beryllium raise risk, especially among smokers. Genetic Influence: Family health history is one of the major contributing factors in making a person more vulnerable. Air Pollution: A high-risk factor; Delhi alone has witnessed an increase in lung cancer cases due to pollution. Diet and Processed Foods: Studies have found that an intake of ultra-processed foods leads to a 41 per cent higher risk, undermining the role played by diet. Regular Screening And Early Detection Dr Raja Dhar, Director & HOD - Pulmonology, CMRI Kolkata, weighed in on the strength of regular screening and early detection. He told NDTV, "Regular screening is also key, particularly for those at greater risk, because it enables us to catch problems early on, when treatment works best. Lung cancer too often gets diagnosed too late, but if we can detect it early, the likelihood of successful treatment is greatly enhanced."
&w=3840&q=100)

Business Standard
2 days ago
- Business Standard
Procter & Gamble Health rallies 10%, hits 4-year high on strong Q1 results
Procter & Gamble Health share price today Shares of Procter & Gamble Health hit a four-year high at ₹6,475, as they rallied 10 per cent on the BSE in Friday's intra-day trade in an otherwise weak market after the company reported strong earnings for the quarter ended June 2025 (Q1FY26). The stock price of the pharmaceutical company was quoting at its lowest level since April 2021. It had hit a record high of ₹7,499.95 on February 11, 2021. At 02:34 PM; Procter & Gamble Health was trading 7 per cent higher at ₹6,312.10, as compared to 0.40 per cent decline in the BSE Sensex. Q1 results - Procter & Gamble Health Procter & Gamble Health delivered a strong performance with sales of ₹333 crore, up 20 per cent against a year ago, owing to broad-based growth in domestic and exports business. Profit after tax (PAT) stood at ₹66 crore, against ₹17 crore a year ago, due to strong sales growth and one-time impact of impairment in the base period. Commenting on the performance, Milind Thatte, Managing Director, P&G Health India, said, "We are pleased with the continued momentum and strong start to the Financial Year 2025-26. These results are a reflection of our commitment towards addressing the evolving needs of our consumers and healthcare professionals, via superior brand building and go to market initiatives while improving supply chain capabilities'. The company's strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption and an agile accountable organization, is delivering balanced and sustainable growth results, Milind Thatte said. Opportunities, outlook The healthcare sector in India has undergone a significant transformation, fueled by substantial investments in infrastructural development. Since 2016, the Indian healthcare industry has witnessed a consistent growth trajectory. The consumer healthcare sector shows promising prospects for the future. The company is well-positioned to sustain and strengthen its position in the market. About Procter & Gamble Health Procter & Gamble Health Limited is one of India's largest vitamins, minerals, and supplements (VMS) companies manufacturing and marketing VMS products for a healthy lifestyle and improved quality of life, including Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion. P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Ambi Pur, Ariel, Gillette, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide, Vicks, and Whisper. P&G operates in approximately 70 countries worldwide.